Irbesartan (versus unexposed) updated on 03-11-2025

Major congenital malformations

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S14413
R57236		 Colvin, 2010 Birth defects (> 90% majors) 1st trimester retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: No Indications Antihypertensive: All hypertensions, any indications or not specified 3.40 [1.00;11.50] 3/21   4,992/106,053 4,995 21
ref
Total 1 studies 3.40 [1.00;11.53] 4,995 21
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Colvin, 2010Colvin, 2010 3.40[1.00; 11.50]4,995210%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate0.910.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 3.40[1.00; 11.53]4,99521 -NAColvin, 2010 1 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 3.40[1.00; 11.53]4,99521 -NAColvin, 2010 1 Tags Adjustment   - No  - No 3.40[1.00; 11.53]4,99521 -NAColvin, 2010 1 Indications Antihypertensive   - All hypertensions, any indications ...  - All hypertensions, any indications or not specified 3.40[1.00; 11.53]4,99521 -NAColvin, 2010 1 All studiesAll studies 3.40[1.00; 11.53]4,99521 -NAColvin, 2010 10.510.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 3.40[1.00; 11.53]4,99521 -NAColvin, 2010 10.510.01.0